Investigation | N (%) |
---|---|
Pelvic ultrasound | 169 (87.1) |
Complete blood count (cbc) | 146 (75.3) |
Thyroid function tests | 80 (41.2) |
Endometrial biopsy* | 49 (25.3) |
Iron and/or serum ferritin | 48 (24.7) |
Dilatation and curettage* | 47 (24.2) |
International normalized ratio (INR)/ prothrombin time (PT) | 46 (23.7) |
Platelets | 46 (23.7) |
Pap smear | 45 (23.2) |
Pelvic exam | 33 (17.0) |
Partial thromboplastin time | 30 (15.5) |
Follicle stimulating hormone (FSH) | 22 (11.3) |
Luteinizing hormone (LH) | 18 (9.3) |
Glucose | 10 (5.2) |
Abdominal exam | 8 (4.1) |
Estrogen | 8 (4.1) |
Pregnancy test (beta HCG) | 8 (4.1) |
Prolactin | 7 (3.6) |
Progesterone | 4 (2.1) |
Referral (no investigations) | 4 (2.1) |